These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 25913726)
1. Oral anticoagulants and risk of nephropathy. Narasimha Krishna V; Warnock DG; Saxena N; Rizk DV Drug Saf; 2015 Jun; 38(6):527-33. PubMed ID: 25913726 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity. Kalaitzidis RG; Duni A; Liapis G; Balafa O; Xiromeriti S; Rapsomanikis PK; Elisaf MS Int Urol Nephrol; 2017 Aug; 49(8):1401-1407. PubMed ID: 28161838 [TBL] [Abstract][Full Text] [Related]
3. Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Ryan M; Ware K; Qamri Z; Satoskar A; Wu H; Nadasdy G; Rovin B; Hebert L; Nadasdy T; Brodsky SV Nephrol Dial Transplant; 2014 Dec; 29(12):2228-34. PubMed ID: 24009280 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulant-related nephropathy: Focus on novel agents. A review. Zakrocka I; Załuska W Adv Clin Exp Med; 2022 Feb; 31(2):165-173. PubMed ID: 35212199 [TBL] [Abstract][Full Text] [Related]
5. An unusual cause of glomerular hematuria and acute kidney injury in a chronic kidney disease patient during warfarin therapy. Santos C; Gomes AM; Ventura A; Almeida C; Seabra J Nefrologia; 2013; 33(3):400-3. PubMed ID: 23712226 [TBL] [Abstract][Full Text] [Related]
6. Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function. Ikeda M; Tanaka M; Shimoda S; Saita H; Nishikawa S; Shimada H; Taniguchi K; Hagihara K; Iwanari S; Takeoka H CEN Case Rep; 2019 Nov; 8(4):292-296. PubMed ID: 31347098 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulant-related nephropathy: A case report. Lee KT; Kammal WSWA; Kong BH Saudi J Kidney Dis Transpl; 2020; 31(6):1403-1406. PubMed ID: 33565454 [TBL] [Abstract][Full Text] [Related]
8. Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants? Ware KM; Vance JC; Muni N; Hebert LA; Satoskar AA; Nadasdy G; Ivanov I; Nadasdy T; Rovin BH; Brodsky SV Am J Hypertens; 2015 Feb; 28(2):182-9. PubMed ID: 25023204 [TBL] [Abstract][Full Text] [Related]
10. Role of glomerular filtration rate-modifying drugs in the development of anticoagulant-related nephropathy. Medipally AK; Xiao M; Rovin BH; Satoskar AA; Ivanov I; Qaisar S; Brodsky SV Physiol Rep; 2021 Jan; 9(1):e14697. PubMed ID: 33427414 [TBL] [Abstract][Full Text] [Related]
11. Warfarin related nephropathy: the first case report in Thailand. Larpparisuth N; Cheunsuchon B; Chawanasuntorapoj R; Vasuvattakul S; Vareesangthip K J Med Assoc Thai; 2015 Feb; 98(2):212-6. PubMed ID: 25842804 [TBL] [Abstract][Full Text] [Related]
13. Warfarin Related Kidney Damage: A Confusing Case of Thrombophlebitis Masquerading as Infection. Brittanee S; Matthew D; Hannah S; Gregory G J Prim Care Community Health; 2023; 14():21501319231159978. PubMed ID: 36932865 [TBL] [Abstract][Full Text] [Related]
14. [Warfarin-related nephropathy: a case report]. Zerah L; Brochériou I; Galichon P; Peltier J; Hertig A Rev Med Interne; 2015 Jan; 36(1):51-4. PubMed ID: 24309547 [TBL] [Abstract][Full Text] [Related]
15. Warfarin-related nephropathy with acute kidney injury in a patient with immunoglobulin A nephropathy. Ishii H; Hirai K; Yanai K; Kitano T; Shindo M; Miyazawa H; Ito K; Ueda Y; Kaku Y; Hoshino T; Mori H; Ookawara S; Ueda Y; Morishita Y CEN Case Rep; 2018 Nov; 7(2):198-203. PubMed ID: 29574675 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243 [No Abstract] [Full Text] [Related]
17. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know. Steed MB; Swanson MT Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772 [TBL] [Abstract][Full Text] [Related]
18. Dabigatran-induced nephropathy and its successful treatment with Idarucizumab - case report and literature review. Awesat J; Sagy I; Haviv YS; Rabinovich A; Jotkowitz A; Shleyfer E; Barski L Thromb Res; 2018 Sep; 169():120-122. PubMed ID: 30032039 [TBL] [Abstract][Full Text] [Related]
19. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data. Tummala R; Kavtaradze A; Gupta A; Ghosh RK Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use. Deng ZL; Yang WL; Zhao XY; Tang ZY; Zheng DX; Wang Y Ren Fail; 2022 Jan; 44(1):30-33. PubMed ID: 35086437 [No Abstract] [Full Text] [Related] [Next] [New Search]